Острые респираторные вирусные инфекции у обезьян
- Авторы: Догадов Д.И.1, Кюрегян К.К.2,3,4, Миносян А.А.1, Гончаренко А.М.1, Шмат Е.В.5, Михайлов М.И.2,3
-
Учреждения:
- Курчатовский комплекс медицинской приматологии ФГБУ НИЦ «Курчатовский институт»
- ФБУН «Центральный научно-исследовательский институт эпидемиологии» Роспотребнадзора
- ФГБНУ «Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова»
- ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
- Сочинский институт (филиал) ФГАОУ ВО РУДН им. Патриса Лумумбы
- Выпуск: Том 70, № 1 (2025)
- Страницы: 7-24
- Раздел: ОБЗОРЫ
- URL: https://bakhtiniada.ru/0507-4088/article/view/287906
- DOI: https://doi.org/10.36233/0507-4088-293
- EDN: https://elibrary.ru/rzmdum
- ID: 287906
Цитировать
Полный текст
Аннотация
Острые респираторные вирусные инфекции (ОРВИ) являются одной из наиболее серьезных проблем, влияющих на разведение обезьян, особенно среди импортированных и содержащихся в неволе приматов. Респираторные заболевания также являются значимой причиной заболеваемости и смертности в диких популяциях, большинство этих инфекций также могут поражать и людей. Многие виды обезьян, включая антропоидов, восприимчивы к ОРВИ. Вспышки спонтанных респираторных инфекций описаны во многих зоопарках и приматологических центрах мира. Вместе с тем изучение спонтанной и экспериментальной инфекции у лабораторных приматов представляет собой бесценный источник информации о биологии и патогенезе ОРВИ и по-прежнему является незаменимым инструментом для тестирования вакцин и лекарственных препаратов. Целью данного обзора литературы являлось обобщение и анализ опубликованных данных о циркуляции ОРВИ (вирусы парагриппа, аденовирусы, респираторно-синцитиальный вирус, вирусы гриппа, риновирусы, коронавирусы, метапневмовирусы, бокавирусы) среди диких и содержащихся в неволе приматов, а также результатов экспериментов по моделированию этих инфекций на обезьянах.
Полный текст
Открыть статью на сайте журналаОб авторах
Дмитрий Игоревич Догадов
Курчатовский комплекс медицинской приматологии ФГБУ НИЦ «Курчатовский институт»
Автор, ответственный за переписку.
Email: dima_loko86@mail.ru
ORCID iD: 0000-0003-1596-0509
канд. биол. наук, начальник лаборатории инфекционных вирусов
Россия, 354376, г. СочиКарен Каренович Кюрегян
ФБУН «Центральный научно-исследовательский институт эпидемиологии» Роспотребнадзора; ФГБНУ «Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова»; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Email: karen-kyuregyan@yandex.ru
ORCID iD: 0000-0002-3599-117X
д-р биол. наук, профессор РАН, заведующий лабораторией молекулярной эпидемиологии вирусных гепатитов ФБУН ЦНИИ Эпидемиологии Роспотребнадзора, ведущий научный сотрудник лаборатории вирусных гепатитов ФГБНУ «НИИ вакцин и сывороток им. И.И. Мечникова»
Россия, 111123, г. Москва; 105064, г. Москва; 125993, г. МоскваАльберт Артурович Миносян
Курчатовский комплекс медицинской приматологии ФГБУ НИЦ «Курчатовский институт»
Email: malbert97@bk.ru
ORCID iD: 0009-0007-6459-1451
лаборант-исследователь лаборатории инфекционных вирусов
Россия, 354376, г. СочиАлександра Михайловна Гончаренко
Курчатовский комплекс медицинской приматологии ФГБУ НИЦ «Курчатовский институт»
Email: morgan_123@rambler.ru
ORCID iD: 0000-0002-6979-9784
научный сотрудник лаборатории инфекционных вирусов
Россия, 354376, г. СочиЕлена Викторовна Шмат
Сочинский институт (филиал) ФГАОУ ВО РУДН им. Патриса Лумумбы
Email: shmatlena@mail.ru
ORCID iD: 0009-0007-0610-7131
канд. тех. наук, доцент, заведующая кафедрой ветеринарной медицины и ветеринарно-санитарной экспертизы
Россия, 354348, г. СочиМихаил Иванович Михайлов
ФБУН «Центральный научно-исследовательский институт эпидемиологии» Роспотребнадзора; ФГБНУ «Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова»
Email: michmich2@yandex.ru
ORCID iD: 0000-0002-6636-6801
д-р мед. наук, профессор, член-корр. РАН, главный научный сотрудник лаборатории молекулярной эпидемиологии вирусных гепатитов ФБУН ЦНИИ Эпидемиологии Роспотребнадзора, заведующий лабораторией вирусных гепатитов, ФГБНУ «НИИ вакцин и сывороток им. И.И. Мечникова»
Россия, 111123, г. Москва; 105064, г. МоскваСписок литературы
- Peltola V., Ruuskanen O. Editorial commentary: Respiratory viral infections in developing countries: common, severe, and unrecognized. Clin. Infect. Dis. 2008; 46(1): 58–60. https://doi.org/10.1086/524020
- Lemaitre J., Naninck T., Delache B., Creppy J., Huber P., Holzapfel M., et al. Non-human primate models of human respiratory infections. Mol. Immunol. 2021; 135: 147–64. https://doi.org/10.1016/j.molimm.2021.04.010
- Понежева Ж.Б., Николаева С.В., Турапова А.Н., Горелов А.В. Актуальные вопросы респираторных инфекций. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2023; 13(2): 51–5. https://doi.org/10.18565/epidem.2023.13.2.51-5 https://elibrary.ru/iermkv
- Lowenstine L.J., Osborn K.J. Respiratory system diseases of nonhuman primates. In: Nonhuman Primates in Biomedical Research. Elsevier; 2012: 413–81. https://doi.org/10.1016/B978-0-12-381366-4.00009-2
- Sasaki M., Ishii A., Orba Y., Thomas Y., Hang’ombe B.M., Moonga L., et al. Human parainfluenza virus type 3 in wild nonhuman primates, Zambia. Emerg. Infect. Dis. 2013; 19(9): 1500–3. https://doi.org/10.3201/eid1909.121404
- Henrickson K.J. Parainfluenza viruses. Clin. Microbiol. Rev. 2003; 16(2): 242–64. https://doi.org/10.1128/CMR.16.2.242-264.2003
- Skiadopoulos M.H., Surman S.R., Riggs J.M., Elkins W.R., Claire M.S., Nishio M., et al. Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees. Virology. 2002; 297(1): 153–60. https://doi.org/10.1006/viro.2002.1416
- Kalter S.S., Heberling R.L., Cooke A.W., Barry J.D., Tian P.Y., Northam W.J. Viral infections of nonhuman primates. Lab. Anim. Sci. 1997; 47(5): 461–7.
- Корзая Л.И., Догадов Д.И., Гончаренко А.М., Карлсен А.А., Кюрегян К.К., Михайлов М.И. Распространение маркёров респираторных вирусов человека среди обезьян Адлерского приматологического центра. Вопросы вирусологии. 2022; 66(6): 425–33. https://doi.org/10.36233/0507-4088-77 https://elibrary.ru/cbntjh
- Догадов Д.И., Кюрегян К.К., Гончаренко А.М., Миносян А.А., Кочконян А.А., Карлсен А.А. и др. Маркеры антропонозных вирусных инфекций у зеленых мартышек, поступивших из мест естественного обитания (Танзания). Вопросы вирусологии. 2023; 68(5): 394–403. https://doi.org/10.36233/0507-4088-188 https://elibrary.ru/awajxs
- Jones-Engel L., Engel G.A., Schillaci M.A., Babo R., Froehlich J. Detection of antibodies to selected human pathogens among wild and pet macaques (Macaca tonkeana) in Sulawesi, Indonesia. Am. J. Primatol. 2001; 54(3): 171–8. https://doi.org/10.1002/ajp.1021
- Bailly J.E., McAuliffe J.M., Durbin A.P., Elkins W.R., Collins P.L., Murphy B.R. A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates. J. Virol. 2000; 74(7): 3188–95. https://doi.org/10.1128/jvi.74.7.3188-3195.2000
- Zhan X., Slobod K.S., Jones B.G., Sealy R.E., Takimoto T., Boyd K., et al. Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats. Int. Immunol. 2015; 27(5): 229–36. https://doi.org/10.1093/intimm/dxu107
- Hawthorne J.D., Lorenz D., Albrecht P. Infection of marmosets with parainfluenza virus types 1 and 3. Infect. Immun. 1982; 37(3): 1037–41. https://doi.org/10.1128/iai.37.3.1037-1041.1982
- Rijsbergen L. C., Schmitz K.S., Begeman L., Drew-Bear J., Gommers L., Lamers M.M., et al. Modeling infection and tropism of human parainfluenza virus type 3 in ferrets. mBio. 2021; 13(1): e0383121. https://doi.org/10.1128/mbio.03831-21.
- Mutanda L.N., Mufson M.A. Antibodies to viruses of human origin in monkeys from Uganda. Proc. Soc. Exp. Biol. Med. 1974; 145(3): 1069–73. https://doi.org/10.3181/00379727-145-37955
- Schillaci M.A., Jones-Engel L., Engel G.A., Kyes R.C. Exposure to human respiratory viruses among urban performing monkeys in Indonesia. Am. J. Trop. Med. Hyg. 2006; 75(4): 716–9.
- Догадов Д.И., Корзая Л.И., Кюрегян К.К., Карлсен А.А., Михайлов М.И. Маркёры вирусного гепатита Е (Hepeviridae, Orthohepevirus, Orthohepevirus A) у импортированных низших обезьян Старого Света. Вопросы вирусологии. 2021; 66(3): 182–8. https://doi.org/10.36233/0507-4088-34 https://elibrary.ru/xvmkmz
- Durbin A. African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection. Vaccine. 2000; 18(22): 2462–9. https://doi.org/10.1016/S0264-410X(99)00575-7
- Корзая Л.И., Кебурия В.В., Гончаренко А.М., Догадов Д.И., Лапин Б.А. Маркёры вирусных инфекций у лабораторных приматов. В кн.: Материалы второй международной научной конференции «Фундаментальные и прикладные аспекты медицинской приматологии». Сочи; 2011: 79–88. https://elibrary.ru/xwiobb
- Churchill A.E. The isolation of parainfluenza 3 virus from fatal cases of pneumonia in erythrocebus patas monkeys. Br. J. Exp. Pathol. 1963; 44(5): 529–37.
- Hawthorne J.D., Albrecht P. Sensitive plaque neutralization assay for parainfluenza virus types 1, 2, and 3 and respiratory syncytial virus. J. Clin. Microbiol. 1981; 13(4): 730–7. https://doi.org/10.1128/jcm.13.4.730-737.1981
- Komada H., Tsurudome M., Ueda M., Nishio M, Bando H., Ito Y. Isolation and characterization of monoclonal antibodies to human parainfluenza virus type 4 and their use in revealing antigenic relation between subtypes 4A and 4B. Virology. 1989; 171(1): 28–37. https://doi.org/10.1016/0042-6822(89)90507-2
- King A.M.Q., Adams M.J., Carstens E.B., Lefkowitz E.J. Virus taxonomy: classification and nomenclature of viruses. In: Ninth Report of the International Committee on Taxonomy of Viruses. Amsterdam: Elsevier; 2012.
- Lukashok S.A., Horwitz M.S. New perspectives in adenoviruses. Curr. Clin. Top. Infect. Dis. 1998; 18: 286–305.
- Benkő M., Aoki K., Arnberg N., Davison A.J., Echavarría M., Hess M., et al. ICTV virus taxonomy profile: adenoviridae 2022. J. Gen. Virol. 2022; 103(3): 001721. https://doi.org/10.1099/jgv.0.001721
- Roy S., Vandenberghe L.H., Kryazhimskiy S., Grant R., Calcedo R., Yuan X., et al. Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathogens. 2009; 5(7): e1000503. https://doi.org/10.1371/journal.ppat.1000503
- Maluquer de Motes C., Hundesa A., Almeida F.C., Bofill-Mas S., Girones R. Isolation of a novel monkey adenovirus reveals a new phylogenetic clade in the evolutionary history of simian adenoviruses. Virol. J. 2011; 8: 125. https://doi.org/10.1186/1743-422X-8-125
- Xiang Z., Li Y., Cun A., Yang W., Ellenberg S., Switzer W.M., et al. Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa. Emerg. Infect. Dis. 2006; 12(10): 1596–9. https://doi.org/10.3201/eid1210.060078
- Ersching J., Hernandez M.I.M., Cezarotto F.S., Ferreira J.D.S., Martins A.B., William M., et al. Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys. Virology. 2010; 407(1): 1–6. https://doi.org/10.1016/j.virol.2010.07.043
- Chiu C.Y., Yagi S., Lu X., Yu G., Chen E.C., Liu M., et al. A novel adenovirus species associated with an acute respiratory outbreak in a baboon colony and evidence of coincident human infection. mBio. 2013; 4(2): e00084-13. https://doi.org/10.1128/mBio.00084-13
- Chen E.C., Yagi S., Kelly K.R., Mendoza S.P., Maninger N., Rosenthal A., et al. Cross-species transmission of a novel adenovirus associated with a fulminant pneumonia outbreak in a New World monkey colony. PLoS Pathogens. 2011; 7(8): e1002155. https://doi.org/10.1371/journal.ppat.1002155
- Yu G., Yagi S., Carrion R., Chen E.C., Liu M., Brasky K.M., et al. Experimental cross-species infection of common marmosets by titi monkey adenovirus. PLoS One. 2013; 8(7): e68558. https://doi.org/10.1371/journal.pone.0068558
- Babkin I.V., Tyumentsev A.I., Tikunov A.Yu., Kurilshikov A.M., Ryabchikova E.I., Zhirakovskaya E.V., et al. Evolutionary time-scale of primate bocaviruses. Infect. Gen. Evol. 2013; 14: 265–74. https://doi.org/10.1016/j.meegid.2012.12.023
- Sharp C.P., LeBreton M., Kantola K., Nana A., Le Doux Diffo J., Djoko C.F., et al. Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J. Virol. 2010; 84(19): 10289–96. https://doi.org/10.1128/JVI.01304-10
- Kumakamba C., Lukusa I.N., Kingebeni P.M., N’Kawa F., Losoma J.A., Mulembakani P.M., et al. DNA indicative of human bocaviruses detected in non-human primates in the Democratic Republic of the Congo. J. Gen. Virol. 2018; 99(5): 676–81. https://doi.org/10.1099/jgv.0.001048
- Morris, J. A., R. E. Blount, and R. E. Savage. 1956. Recovery of Cytopathogenic Agent from Chimpanzees with Goryza. Experimental Biology and Medicine 92: 544–549. https://doi.org/10.3181/00379727-92-22538.
- Clarke C.J., Watt N.J., Meredith A., McIntyre N., Burns S.M. Respiratory syncytial virus-associated bronchopneumonia in a young chimpanzee. J. Comp. Pathol. 1994; 110(2): 207–12. https://doi.org/10.1016/s0021-9975(08)80191-0
- Belshe R.B., Richardson L.S., London W.T., Sly D.L., Lorfeld J.H., Camargo E., et al. Experimental respiratory syncytial virus infection of four species of primates. J. Med. Virol. 1977; 1(3): 157–62. https://doi.org/10.1002/jmv.1890010302
- Weltzin R., Traina-Dorge V., Soike K., Zhang J.Y., Mack P., Soman G., et al. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection. J. Infect. Dis. 1996; 174(2): 256–61. https://doi.org/10.1093/infdis/174.2.256
- Simoes E.A., Hayward A.R., Ponnuraj E.M., Straumanis J.P., Stenmark K.R., Wilson H.L., et al. Respiratory syncytial virus infects the Bonnet monkey, Macaca radiata. Pediatr. Dev. Pathol. 1999; 2(4): 316–26. https://doi.org/10.1007/s100249900129
- McArthur-Vaughan K., Gershwin L.J. A rhesus monkey model of respiratory syncytial virus infection. J. Med. Primatol. 2002; 31(2): 61–73. https://doi.org/10.1034/j.1600-0684.2002.01006.x
- Ponnuraj E.M., Hayward A.R., Raj A., Wilson H., Simoes E.A.F. Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. J. Gen. Virol. 2001; 82(Pt. 11): 2663–74. https://doi.org/10.1099/0022-1317-82-11-2663
- Kakuk T.J., Soike K., Brideau R.J., Zaya R.M., Cole S.L., Zhang J.Y., et al. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. J. Infect. Dis. 1993; 167(3): 553–61. https://doi.org/10.1093/infdis/167.3.553
- Papin J.F., Wolf R.F., Kosanke S.D., Jenkins J.D., Moore S.N., Anderson M.P., et al. Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am. J. Physiol. Lung. Cell Mol. Physiol. 2013; 304(8): L530–9. https://doi.org/10.1152/ajplung.00173.2012
- Richardson L.S., Belshe R.B., Sly D.L., London W.T., Prevar D.A., Camargo E., et al. Experimental respiratory syncytial virus pneumonia in cebus monkeys. J. Med. Virol. 1978; 2(1): 45–59. https://doi.org/10.1002/jmv.1890020108
- Koff W.C., Caplan F.R., Case S., Halstead S.B. Cell-mediated immune response to respiratory syncytial virus infection in owl monkeys. Clin. Exp. Immunol. 1983; 53(2): 272–80.
- Taylor G. Animal models of respiratory syncytial virus infection. Vaccine. 2017; 35(3): 469–80. https://doi.org/10.1016/j.vaccine.2016.11.054
- Crowe J.E., Collins P.L., London W.T., Chanock R.M., Murphy B.R. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Vaccine. 1993; 11(14): 1395–404. https://doi.org/10.1016/0264-410X(93)90168-W
- Crowe Jr J.E, Bui P., Davis A., Chanock R., Murphy B. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Vaccine. 1994; 12(9): 783–90. https://doi.org/10.1016/0264-410X(94)90286-0
- Jin H., Cheng X., Traina-Dorge V.L., Park H.J., Zhou H., Soike K., et al. Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates. Vaccine. 2003; 21(25-26): 3647–52. https://doi.org/10.1016/S0264-410X(03)00426-2
- Le Nouën C., Brock L.G., Luongo C., McCarty T., Yang L., Mehedi M., et al. Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization. Proc. Natl. Acad. Sci. USA. 2014; 111(36): 13169–74. https://doi.org/10.1073/pnas.1411290111
- Jones B.G., Sealy R.E., Rudraraju R., Traina-Dorge V.L., Finneyfrock B., Cook A., et al. Sendai virus-based RSV vaccine protects African green monkeys from RSV infection. Vaccine. 2012; 30(5): 959–68. https://doi.org/10.1016/j.vaccine.2011.11.046
- Tang R.S., MacPhail M., Schickli J.H., Kaur J., Robinson C.L., Lawlor H.A., et al. Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys. J. Virol. 2004; 78(20): 11198–207. https://doi.org/10.1128/JVI.78.20.11198-11207.2004
- Eyles J.E., Johnson J.E., Megati S., Roopchand V., Cockle P.J., Weeratna R., et al. Nonreplicating vaccines can protect African green monkeys from the Memphis 37 strain of respiratory syncytial virus. J. Infect. Dis. 2013; 208(2): 319–29. https://doi.org/10.1093/infdis/jit169
- Bates J.T., Pickens J.A., Schuster J.E., Johnson M., Tollefson S.J., Williams J.V., et al. Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates. Vaccine. 2017; 34(7): 950–6. https://doi.org/10.1016/j.vaccine.2015.12.045
- De Swart R.L., Kuiken T., Timmerman H.H., van Amerongen G., Van Den Hoogen B.G., Vos H.W., et al. Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection. J. Virol. 2002; 76(22): 11561–9. https://doi.org/10.1128/jvi.76.22.11561-11569.2002
- Richardson L.S., Belshe R.B., London W.T., Sly D.L., Prevar D.A., Camargo E., et al. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness. J. Med. Virol. 1978; 3(2): 91–100. https://doi.org/10.1002/jmv.1890030202
- Philippot Q., Rammaert B., Dauriat G., Daubin C., Schlemmer F., Costantini A., et al. 2024. Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients. Heliyon. 2024; 10(13): e33231. https://doi.org/10.1016/j.heliyon.2024.e33231
- De Graaf M., Osterhaus A.D.M.E., Fouchier R.A.M., Holmes E.C. Evolutionary dynamics of human and avian metapneumoviruses. J. Gen. Virol. 2008; 89(12): 2933–42. https://doi.org/10.1099/vir.0.2008/006957-0
- Buitendijk H., Fagrouch Z., Niphuis H., Bogers W., Warren K., Verschoor E. Retrospective serology study of respiratory virus infections in captive great Apes. Viruses. 2014; 6(3): 1442–53. https://doi.org/10.3390/v6031442
- Köndgen S., Kühl H., N’Goran P.K., Walsh P.D., Schenk S., Ernst N., et al. Pandemic Human viruses cause decline of endangered great Apes. Curr. Biol. 2008; 18(4): 260–4. https://doi.org/10.1016/j.cub.2008.01.012
- Kaur T., Singh J., Tong S., Humphrey C., Clevenger D., Tan W., et al. Descriptive epidemiology of fatal respiratory outbreaks and detection of a human-related metapneumovirus in wild chimpanzees (Pan troglodytes) at Mahale Mountains National Park, Western Tanzania. Am. J. Primatol. 2008; 70(8): 755–65. https://doi.org/10.1002/ajp.20565
- Palacios G., Lowenstine L.J., Cranfield M.R., Gilardi K.V.K., Spelman L., Lukasik-Braum M. Human metapneumovirus infection in wild mountain gorillas, Rwanda. Emerg. Infect. Dis. 2011; 17(4): 711–3. https://doi.org/10.3201/eid1704.100883
- Slater O.M., Terio K.A., Zhang Y., Erdman D.D., Schneider E., Kuypers J.M., et al. Human metapneumovirus infection in chimpanzees, United States. Emerg. Infect. Dis. 2014; 20(12): 2115–8. https://doi.org/10.3201/eid2012.140408
- Skiadopoulos M.H., Biacchesi S., Buchholz U.J., Riggs J.M., Surman S.R., Amaro-Carambot E., et al. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (f) protein is a major contributor to this antigenic relatedness. J. Virol. 2004; 78(13): 6927–37. https://doi.org/10.1128/JVI.78.13.6927-6937.2004
- Kuiken T., Van Den Hoogen B.G., Van Riel D.A.J., Laman J.D., Van Amerongen G., Sprong L., et al. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am. J. Pathol. 2004; 164(6): 1893–900. https://doi.org/10.1016/S0002-9440(10)63750-9
- MacPhail M., Schickli J.H., Tang R.S., Kaur J., Robinson C., Fouchier R.A.M. Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J. Gen. Virol. 2004; 85(6): 1655–63. https://doi.org/10.1099/vir.0.79805-0
- Schildgen O., Simon A., Williams J. Animal models for human Metapneumovirus (HMPV) infections. Vet. Res. 2007; 38(1): 117–26. https://doi.org/10.1051/vetres:2006051
- Thompson I.M., Goodman P.J., Tangen C.M., Lucia M.S., Miller G.J., Ford L.G., et al. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 2003; 349(3): 215–24. https://doi.org/10.1056/NEJMoa030660
- O’Brien T.C., Tauraso N.M. Antibodies to type A influenza viruses in sera from nonhuman primates. Arch. Gesamte. Virusforsch. 1973; 40(3): 359–65. https://doi.org/10.1007/BF01242556
- Karlsson E.A., Engel G.A., Feeroz M.M., San S., Rompis A., Lee B.P., et al. Influenza virus infection in nonhuman primates. Emerg. Infect. Dis. 2012; 18(10): 1672–5. https://doi.org/10.3201/eid1810.120214
- Bodewes R., Rimmelzwaan G.F., Osterhaus A.D. Animal models for the preclinical evaluation of candidate influenza vaccines. Expert. Rev. Vaccines. 2010; 9(1): 59–72. https://doi.org/10.1586/erv.09.148
- Baskin C.R., Bielefeldt-Ohmann H., Tumpey T.M., Sabourin P.J., Long J.P., García-Sastre A., et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. USA. 2009; 106(9): 3455–60. https://doi.org/10.1073/pnas.0813234106
- Baskin C.R., García-Sastre A., Tumpey T.M., Bielefeldt-Ohmann H., Carter V.S., Nistal-Villán E., et al. Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina). J. Virol. 2004; 78(19): 10420–32. https://doi.org/10.1128/JVI.78.19.10420-10432.2004
- Carroll T.D., Matzinger S.R., Barro M., Fritts L., McChesney M.B., Miller C.J., et al. Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone® in rhesus macaques. Vaccine. 2010; 29(5): 931–40. https://doi.org/10.1016/j.vaccine.2010.11.024
- Chen Y., Deng W., Jia C., Dai X., Zhu H., Kong Q., et al. Pathological lesions and viral localization of influenza A (H5N1) virus in experimentally infected Chinese rhesus macaques: implications for pathogenesis and viral transmission. Arch. Virol. 2009; 154(2): 227–33. https://doi.org/10.1007/s00705-008-0277-5
- Shinya K., Gao Y., Cilloniz C., Suzuki Y., Fujie M., Deng G., et al. Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. J. Virol. 2012; 86(11): 6055–66. https://doi.org/10.1128/JVI.00365-12
- Itoh Y., Ozaki H., Tsuchiya H., Okamoto K., Torii R., Sakoda Y., et al. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine. 2008; 26(4): 562–72. https://doi.org/10.1016/j.vaccine.2007.11.031
- Jegaskanda S., Weinfurter J.T., Friedrich T.C., Kent S.J. Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques. J. Virol. 2013; 87(10): 5512–22. https://doi.org/10.1128/JVI.03030-12
- Matzinger S.R., Carroll T.D., Fritts L., McChesney M.B., Miller C.J. Exogenous IFN-alpha administration reduces influenza a virus replication in the lower respiratory tract of rhesus macaques. PLoS One. 2011; 6(12): e29255. https://doi.org/10.1371/journal.pone.0029255
- Rimmelzwaan G.F., Baars M., Van Amerongen G., Van Beek R., Osterhaus A.D.M.E. A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses. Vaccine. 2001; 20(1-2): 158–63. https://doi.org/10.1016/S0264-410X(01)00262-6
- Rimmelzwaan G.F., Kuiken T., Van Amerongen G., Bestebroer T.M., Fouchier R.A.M., Osterhaus A.D.M.E. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virology. 2001; 75(14): 6687–91. https://doi.org/10.1128/JVI.75.14.6687-6691.2001
- Cillóniz C., Shinya K., Peng X., Korth M.J., Proll S.C., Aicher L.D., et al. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 2009; 5(10): e1000604. https://doi.org/10.1371/journal.ppat.1000604
- Murphy B.R., Hinshaw V.S., Sly D.L., London W.T., Hosier N.T., Wood F.T., et al. Virulence of avian influenza a viruses for squirrel monkeys. Infect. Immun. 1982; 37(3): 1119–26. https://doi.org/10.1128/iai.37.3.1119-1126.1982
- Mooij P., Koopman G., Mortier D., van Heteren M., Oostermeijer H., Fagrouch Z., et al. Pandemic swine-origin H1N1 influenza virus replicates to higher levels and induces more fever and acute inflammatory cytokines in cynomolgus versus rhesus monkeys and can replicate in common marmosets. PloS One. 2015; 10(5): e0126132. https://doi.org/10.1371/journal.pone.0126132
- Jacobs S.E., Lamson D.M., George K.St., Walsh T.J. Human rhinoviruses. Clin. Microbiol. Rev. 2013; 26(1): 135–62. https://doi.org/10.1128/CMR.00077-12
- Negrey J.D., Reddy R.B., Scully E.J., Phillips-Garcia S., Owens L.A., Kevin E., et al. Simultaneous outbreaks of respiratory disease in wild chimpanzees caused by distinct viruses of human origin. Emerg. Microb. Infect. 2019; 8(1): 139–49. https://doi.org/10.1080/22221751.2018.1563456
- Pinto C.A., Haff R.F. Experimental infection of gibbons with rhinovirus. Nature. 1969; 224(526): 1310–1.
- Martin G.V., Heath R.B. Rhinovirus infection of vervet monkeys. Br. J. Exp. Pathol. 1969; 50(5): 516–9.
- V’kovski P., Kratzel A., Steiner S., Stalder H., Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 2021; 19(3): 155–70. https://doi.org/10.1038/s41579-020-00468-6
- Гончарук E.И., Шевцова З.В., Румель Н.Б., Крылова Р.И. Спонтанная коронавирусная инфекция у обезьян. Журнал микробиологии, эпидемиологии и иммунобиологии. 1994; (Прил. 1): 109–14.
- Гончарук Е.И., Шевцова З.В., Крылова Р.И., Румель Н.Б., Стеценко В.И. Экспериментальная коронавирусная инфекция обезьян. Микробиологический журнал (Киев). 1994; 56(3): 65–71.
- Greenough T.C., Carville A., Coderre J., Somasundaran M., Sullivan J.L., Luzuriaga K., et al. Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus. Am. J. Pathol. 2005; 167(2): 455–63. https://doi.org/10.1016/S0002-9440(10)62989-6
- McAuliffe J., Vogel L., Roberts A., Fahle G., Fischer S., Shieh W.J., et al. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology. 2004; 330(1): 8–15. https://doi.org/10.1016/j.virol.2004.09.030
- Qin C., Wang J., Wei Q., She M., Marasco W.A., Jiang H., et al. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J. Pathol. 2005; 206(3): 251–9. https://doi.org/10.1002/path.1769
- Rowe T., Gao G., Hogan R.J., Crystal R.G., Voss T.G., Grant R.L., et al. Macaque model for severe acute respiratory syndrome. J. Virol. 2004; 78(20): 11401–4. https://doi.org/10.1128/JVI.78.20.11401-11404.2004
- Kobinger G.P., Figueredo J.M., Rowe T., Zhi Y., Gao G., Sanmiguel J.C., et al. Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques. Vaccine. 2007; 25(28): 5220–31. https://doi.org/10.1016/j.vaccine.2007.04.065
- Kuiken T., Am Fouchier R., Schutten M., Rimmelzwaan G.F., Van Amerongen G., Van Riel D., et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2023; 362(9380): 263–70. https://doi.org/10.1016/S0140-6736(03)13967-0
- Aid M., Busman-Sahay K., Vidal S.J., Maliga Z., Bondoc S., Starke C., et al. Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques. Cell. 2020; 183(5): 1354–66.e13. https://doi.org/10.1016/j.cell.2020.10.005
- Blair R.V., Vaccari M., Doyle-Meyers L.A., Roy C.J., Russell-Lodrigue K., Fahlberg M., et al. Acute respiratory distress in aged, SARS-CoV-2–infected African green monkeys but not rhesus macaques. Am. J. Pathol. 2021; 191(2): 274–82. https://doi.org/10.1016/j.ajpath.2020.10.016
- Chandrashekar A., Liu J., Martinot A.J., McMahan K., Mercado N.B., Peter L., et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020; 369(6505): 812–7. https://doi.org/10.1126/science.abc4776
- Deng W., Bao L., Liu J., Xiao C., Liu J., Xue J., et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020; 369(6505): 818–23. https://doi.org/10.1126/science.abc5343
- Deng W., Bao L., Gao H., Xiang Z., Qu Y., Song Z., et al. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nat. Commun. 2020; 11(1): 4400. https://doi.org/10.1038/s41467-020-18149-6
- Fahlberg M.D., Blair R.V., Doyle-Meyers L.A., Midkiff C.C., Zenere G., Russell-Lodrigue K.E., et al. Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates. Nat. Commun. 2020; 11(1): 6078. https://doi.org/10.1038/s41467-020-19967-4
- Koo B.S., Oh H., Kim G., Hwang E.H., Jung H., Lee Y., et al. Transient lymphopenia and interstitial pneumonia with endotheliitis in SARS-CoV-2-infected macaques. J. Infect. Dis. 2020; 222(10): 1596–600. https://doi.org/10.1093/infdis/jiaa486
- Lu S., Zhao Y., Yu W., Yang Y., Gao J., Wang J., et al. Comparison of nonhuman primates identified the suitable model for COVID-19. Signal. Transduct. Target. Ther. 2020; 5(1): 157. https://doi.org/10.1038/s41392-020-00269-6
- Munster V.J., Feldmann F., Williamson B.N., Van Doremalen N., Pérez-Pérez L., Schulz J., et al. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020; 585(7824): 268–72. https://doi.org/10.1038/s41586-020-2324-7
- Rosa B.A., Ahmed M., Singh D.K., Choreño-Parra J.A., Cole J., Jiménez-Álvarez L.A., et al. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun. Biol. 2021; 4(1): 290. https://doi.org/10.1038/s42003-021-01829-4
- Salguero F.J., White A.D., Slack G.S., Fotheringham S.A., Bewley K.R., Gooch K.E., et al. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19. Nat. Commun. 2021; 12(1): 1260. https://doi.org/10.1038/s41467-021-21389-9
- Shan C., Yao Y.F., Yang XL., Zhou YW., Gao G., Peng Y., et al. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques. Cell Res. 2020; 30(8): 670–7. https://doi.org/10.1038/s41422-020-0364-z
- Singh D.K., Singh B., Ganatra S.R., Gazi M., Cole J., Thippeshappa R., et al. Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets. Nat. Microbiol. 2020; 6(1): 73–86. https://doi.org/10.1038/s41564-020-00841-4
- Song T.Z., Zheng H.Y., Han J.B., Jin L., Yang X., Liu F.L., et al. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques. Zool. Res. 2020; 41(5): 503–16. https://doi.org/10.24272/j.issn.2095-8137.2020.202
- Yu P., Qi F., Xu Y., Li F., Liu P., Liu J., et al. Age-related rhesus macaque models of COVID-19. Animal Model Exp. Med. 2020; 3(1): 93–7. https://doi.org/10.1002/ame2.12108
- Zheng H., Li H., Guo L., Liang Y., Li J., Wang X., et al. Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression. PLoS Pathog. 2020; 16(11): e1008949. https://doi.org/10.1371/journal.ppat.1008949
- Johnston S.C., Ricks K.M., Jay A., Raymond J.L., Rossi F., Zeng X., et al. Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure. PLoS One. 2021; 16(2): e0246366. https://doi.org/10.1371/journal.pone.0246366
- Ishigaki H., Nakayama M., Kitagawa Y., Nguyen C.T., Hayashi K., Shiohara M., et al. Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques. Virology. 2021; 554: 97–105. https://doi.org/10.1016/j.virol.2020.12.013
- Rockx B., Kuiken T., Herfst S., Bestebroer T., Lamers M.M., Munnink B.B.O., et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020; 368(6494): 1012–5. https://doi.org/10.1126/science.abb7314
- Cross R.W., Agans K.N., Prasad A.N., Borisevich V., Woolsey C., Deer D.J., et al. Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase. Virol. J. 2020; 17(1): 125. https://doi.org/10.1186/s12985-020-01396-w
- Hartman A.L., Nambulli S., McMillen C.M., White A.G., Tilston-Lunel N.L., Albe J.R., et al. SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts. PLoS Pathog. 2020; 16(9): e1008903. https://doi.org/10.1371/journal.ppat.1008903
- Speranza E., Williamson B.N., Feldmann F., Sturdevant G.L., Pérez-Pérez L., Meade-White K., et al. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci. Transl. Med. 2021; 13(578): eabe8146. https://doi.org/10.1126/scitranslmed.abe8146.
- Woolsey C., Borisevich V., Prasad A.N., Agans K.N., Deer D.J., Dobias N.S., et al. Establishment of an African green monkey model for COVID-19 and protection against re-infection. Nat. Immunol. 2021; 22(1): 86–98. https://doi.org/10.1038/s41590-020-00835-8.
- Erasmus J.H., Khandhar A.P., O’Connor M.A., Walls A.C., Hemann E.A., Murapa P., et al. An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Sci. Transl. Med. 2020; 12: eabc9396. https://doi.org/10.1126/scitranslmed.abc9396
- Tian J.H., Patel N., Haupt R., Zhou H., Weston S., Hammond H., et al. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nat. Commun. 2021; 12(1): 372. https://doi.org/10.1038/s41467-020-20653-8
- Walls A.C., Fiala B., Schäfer A., Wrenn S., Pham M.N., Murphy M., et al. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. Cell. 2020; 183(5): 1367–82.e17. https://doi.org/10.1016/j.cell.2020.10.043
- Liu Z.J., Qian X.K., Hong M.H., Zhang J.L., Li D.Y., Wang T.H., et al. Global view on virus infection in non-human primates and implications for public health and wildlife conservation. Zool. Res. 2021; 42(5): 626–32. https://doi.org/10.24272/j.issn.2095-8137.2021.080
- Cano-Terriza D., Beato-Benítez A., Fernández-Bastit L., Segalés J., Vergara-Alert J., Martínez-Nevado E., et al. SARS-CoV-2 in captive nonhuman primates, Spain, 2020–2023. Emerg. Infect. Dis. 2024; 30(6): 1253–7. https://doi.org/10.3201/eid3006.231247.
- Dusseldorp F., Bruins-van-Sonsbeek L.G.R., Buskermolen M., Niphuis H., Dirven M., Whelan J., et al. SARS-CoV-2 in lions, gorillas and zookeepers in the Rotterdam Zoo, the Netherlands, a One Health investigation, November 2021. Euro Surveill. 2023; 28(28): 2200741. https://doi.org/10.2807/1560-7917.ES.2023.28.28.2200741
- Nagy A., Stará M., Vodička R., Černíková L., Jiřincová H., Křivda V., et al. Reverse-zoonotic transmission of SARS-CoV-2 lineage alpha (B.1.1.7) to great apes and exotic felids in a zoo in the Czech Republic. Arch. Virol. 2022; 167(8): 1681–5. https://doi.org/10.1007/s00705-022-05469-9
- Yaglom H.D., Roth A., Alvarez C., Corbus E., Ghai R.R., Ferguson S., et al. Detection of SARS-CoV-2 in a squirrel monkey (Saimiri sciureus): a one health investigation and response. J. Zoo Wildl. Med. 2024; 55(2): 471–8. https://doi.org/10.1638/2023-0052
- Carvajal M., Saenz C., Fuentes N., Guevara R., Muñoz E., Prado-Vivar B., et al. SARS-CoV-2 infection in brown-headed spider monkeys (Ateles fusciceps) at a wildlife rescue center on the coast of Ecuador-South America. Microbiol. Spectr. 2024; 12(4): e0274123. https://doi.org/10.1128/spectrum.02741-23
Дополнительные файлы
